PemBla: a Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer
<p><strong>Objectives:</strong> This study aimed to investigate the anti-PD-1 inhibitor pembrolizumab as a potential agent for use in non-muscle-invasive bladder cancer (NMIBC) by conducting a Phase 1 safety run-in study to assess the safety and tolerability of intravesical pembrol...
Hlavní autoři: | Woodcock, VK, Chen, J-L, Purshouse, K, Butcher, C, Collins, L, Haddon, C, Verrall, G, Elhussein, L, Roberts, C, Tarlton, A, Rei, M, Napolitani, G, Salio, M, Middleton, MR, Cerundolo, V, Crew, J, Protheroe, AS |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Wiley
2023
|
Podobné jednotky
-
PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer
Autor: Victoria K. Woodcock, a další
Vydáno: (2023-05-01) -
Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experience
Autor: Karin Purshouse, a další
Vydáno: (2019-01-01) -
The role of invariant natural killer T (iNKT) cells in modulating the lung inflammatory response during influenza A virus infection
Autor: McEwen-Smith, R, a další
Vydáno: (2013) -
P105 (0032) A PHASE II STUDY OF PEMBROLIZUMAB (PEM) FOLLOWED BY AVD FOR FRONTLINE TREATMENT OF CLASSICAL HODGKIN LYMPHOMA (CHL): INTERIM RESULTS
Vydáno: (2018-10-01) -
Intravesical protrusion of giant median prostatic lobe: A case report
Autor: M. Duijn, a další
Vydáno: (2022-09-01)